Publications
2 November 2026
Discover tRIBO-seq, a nanopore-based method to profile actively translating tRNAs and reveal changes in their abundance, modifications and fragmentation under stress.
Publications
28 October 2026
Researchers identify AARS1 as a potential target in ovarian cancer. Using Ribo-seq and multi-omics approaches, the study shows how AARS1 regulates IRF7 translation and type I interferon signaling, revealing a way to improve antitumor immunity.
Publications
19 October 2026
A study published in Nature Cell Biology reveals how ADAR1 and FTSJ1 regulate mistranslation in cancer cells under tryptophan-limiting conditions. IMMAGINA Biotechnology contributed nano-tRNA sequencing expertise to investigate the role of tRNA modificati
Publications
6 October 2026
A study reveals how Kozak sequences influence translation efficiency and mRNA stability in Leishmania, uncovering a previously underexplored mechanism of gene expression regulation and parasite adaptation.
Publications
2 October 2026
Researchers uncover how Ezrin and eIF4E coordinate localized protein translation in AML cells, supporting cell movement and disease progression. The findings reveal a new link between translation machinery and leukemia cell motility.
Resources
15 September 2026
Immagina BioTechnology is featured in a Nature Biotechnology article highlighting the growing interest in the dark proteome and the technologies helping researchers uncover previously overlooked proteins.